In Korea, doctors are exploring a new way to manage low-risk thyroid cancer. Instead of rushing into surgery, they're considering an approach called active surveillance (AS). This means keeping a close eye on the cancer without immediate surgery. But not all doctors are ready to embrace this idea. A recent survey found several concerns. Let's dive into what's holding them back.

One big worry is the lack of clear guidelines. Doctors need a solid roadmap to navigate this new approach. Another concern is the uncertainty of watching and waiting. Doctors fear that the cancer might grow quickly, making surgery more difficult later. They also worry about how constant monitoring might affect patients' emotions. Some patients might prefer the finality of surgery to reduce anxiety.

Patient preferences play a big role too. Some want the cancer removed right away, while others are okay with the surveillance approach. Balancing these preferences with medical advice can be a challenge. Additionally, insurance coverage is a hurdle. Not all health plans cover active surveillance, which can make it a less attractive option for some patients.

Despite these hurdles, active surveillance is gaining traction. It offers a less invasive path for patients with low-risk thyroid cancer. As more research is done and guidelines improve, we can expect more doctors to adopt this approach.

Watching and Waiting: A New Way to Handle Low-Risk Thyroid Cancer in Korea

Actions